4th Dec 2015 09:15
LONDON (Alliance News) - Stem cell therapy development company ReNeuron Group PLC on Friday said it has appointed Mike Owen as a non-executive director with immediate effect.
Owen is the former senior vice-president for biopharmaceutical research at GlaxoSmithKline PLC, the FTSE 100-listed drugmaker.
He also will sit on the ReNeuron's Scientific Advisory Board.
ReNeuron shares were down 1.0% to 2.8475 pence on Friday.
By Sam Unsted; [email protected]; @SamUAtAlliance
Copyright 2015 Alliance News Limited. All Rights Reserved.
Related Shares:
GlaxosmithklineRENE.L